We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+15.61%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.74B
AUM Growth
+$743M
Cap. Flow
+$207M
Cap. Flow %
4.37%
Top 10 Hldgs %
17.46%
Holding
1,440
New
165
Increased
569
Reduced
526
Closed
100

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$9.67M
2
LOW icon
Lowe's Companies
LOW
+$6.73M
3
ALB icon
Albemarle
ALB
+$5.55M
4
VEEV icon
Veeva Systems
VEEV
+$5.27M
5
CHWY icon
Chewy
CHWY
+$5.11M

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 11.15%
3 Financials 10.55%
4 Consumer Discretionary 9.84%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROP icon
876
Roper Technologies
ROP
$38.9B
$509K 0.01%
1,180
-114
-9% -$46.8K
XLE icon
877
State Street Energy Select Sector SPDR ETF
XLE
$39.7B
$508K 0.01%
26,814
-3,190
-11% -$55K
RGEN icon
878
Repligen
RGEN
$9.37B
$504K 0.01%
+2,633
New +$479K
OXFD
879
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$504K 0.01%
28,900
-60,400
-68% -$847K
IR icon
880
Ingersoll Rand
IR
$32.8B
$503K 0.01%
11,028
-631
-5% -$26.1K
USMV icon
881
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
$503K 0.01%
7,414
-16,254
-69% -$1.07M
AN icon
882
AutoNation
AN
$6.85B
$502K 0.01%
+7,196
New +$452K
ZD icon
883
Ziff Davis
ZD
$1.89B
$502K 0.01%
5,914
EVH icon
884
Evolent Health
EVH
$495M
$497K 0.01%
31,000
OEF icon
885
iShares S&P 100 ETF
OEF
$20.4B
$497K 0.01%
2,898
WIX icon
886
WIX.com
WIX
$2.77B
$497K 0.01%
1,990
-255
-11% -$67.2K
NTR icon
887
Nutrien
NTR
$31.8B
$496K 0.01%
+10,293
New +$455K
IVOL icon
888
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$271M
$495K 0.01%
17,715
+5,260
+42% +$145K
KALU icon
889
Kaiser Aluminum
KALU
$3.11B
$495K 0.01%
5,000
BAB icon
890
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
$493K 0.01%
14,702
+33
+0.2% +$1.09K
CVNA icon
891
Carvana
CVNA
$77.6B
$493K 0.01%
10,290
-390
-4% -$17.8K
VST icon
892
Vistra
VST
$49.2B
$492K 0.01%
25,000
+7,900
+46% +$147K
DBP icon
893
Invesco DB Precious Metals Fund
DBP
$260M
$489K 0.01%
9,268
+21
+0.2% +$1.08K
EL icon
894
Estee Lauder
EL
$31.9B
$489K 0.01%
1,838
+117
+7% +$28.1K
FLG
895
Flagstar Bank National Association
FLG
$5.93B
$489K 0.01%
15,423
+180
+1% +$4.97K
DWAS icon
896
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$451M
$488K 0.01%
6,488
-304
-4% -$20.7K
NTNX icon
897
Nutanix
NTNX
$17.3B
$488K 0.01%
15,292
+1,840
+14% +$49.9K
PRU icon
898
Prudential Financial
PRU
$42.2B
$487K 0.01%
6,244
+732
+13% +$52.9K
ACA icon
899
Arcosa
ACA
$7.13B
$485K 0.01%
8,841
+3,948
+81% +$201K
BND icon
900
Vanguard Total Bond Market
BND
$161B
$485K 0.01%
5,502
+273
+5% +$24K

Similar funds

Oppenheimer & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Oppenheimer & Co held 1,440 positions worth $4.74B, up 19% from $4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co deployed $207M of net new capital in Q4 2020, opening 165 new positions and adding to 569 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 152,386 shares worth $16.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was ProShares Short S&P500, an estimated $9.67M trimmed.

  • Oppenheimer & Co's largest Q4 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 152,386 shares worth $16.6M.
  • Oppenheimer & Co added most to Vanguard Intermediate-Term Bond ETF in Q4 2020, an estimated $20.3M increase.
  • Oppenheimer & Co's biggest Q4 2020 reduction was ProShares Short S&P500, cutting an estimated $9.67M.
  • Oppenheimer & Co fully exited PagerDuty in Q4 2020, selling an estimated $2.96M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.74B portfolio in Q4 2020.
  • Oppenheimer & Co opened 165 new positions and closed 100 in Q4 2020.
  • Oppenheimer & Co's portfolio value rose 19% quarter-over-quarter to $4.74B.

Based on Oppenheimer & Co's 13F filing for Q4 2020, filed 11 Feb 2021.